Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Deficiency Disorder”

Showing 20 of 0 results

Not applicableStudy completedNCT04481373
What this trial is testing

Targeting HIV Retention and Improved Viral Load Through Engagement ('THRIVE')

Who this might be right for
Human Immunodeficiency VirusDepressionAnxiety
Baylor College of Medicine 75
Early research (Phase 1)UnknownNCT03189394
What this trial is testing

Trial to Prevent HIV Among Gay Couples

Who this might be right for
HIV Infections
San Francisco State University 600
Not applicableLooking for participantsNCT05159466
What this trial is testing

Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors

Who this might be right for
Human Immunodeficiency VirusEnd Stage Renal Disease
Tulane University 30
Post-approval studies (Phase 4)Ended earlyNCT00981773
What this trial is testing

The St. Marys and The Mater Switch Study

Who this might be right for
HIV Infections
Imperial College London 18
Large-scale testing (Phase 3)Ended earlyNCT00004986
What this trial is testing

Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients

Who this might be right for
CryptosporidiosisHIV Infections
Romark Laboratories L.C. 30
Not applicableStudy completedNCT00231972
What this trial is testing

Enhancing HIV Prevention by Using Behavioral Intervention Among HIV-Infected Men

Who this might be right for
HIV Infections
Fenway Community Health 201
Not applicableUnknownNCT06578702
What this trial is testing

Evaluation of Intermittent Triple Therapies in Real Life

Who this might be right for
HIV Infections
University Hospital, Strasbourg, France 200
Early research (Phase 1)Study completedNCT00000986
What this trial is testing

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT00056641
What this trial is testing

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 328
Not applicableWithdrawnNCT03405194
What this trial is testing

Same-Day Treatment With Genvoya vs. EFV/TDF/3TC

Who this might be right for
HIV/AIDS
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Testing effectiveness (Phase 2)Ended earlyNCT00865566
What this trial is testing

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,504
Testing effectiveness (Phase 2)Study completedNCT00885495
What this trial is testing

Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study

Who this might be right for
HIV Infections
University of Cincinnati 17
Not applicableActive Not RecruitingNCT05965245
What this trial is testing

Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth

Who this might be right for
DepressionHIV Infection
Washington University School of Medicine 248
Early research (Phase 1)Study completedNCT00002353
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Large-scale testing (Phase 3)Study completedNCT03222583
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 546
Post-approval studies (Phase 4)Study completedNCT00402454
What this trial is testing

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Who this might be right for
HIV Infections
Sociedad Andaluza de Enfermedades Infecciosas 300
Large-scale testing (Phase 3)Study completedNCT00421551
What this trial is testing

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 225
Not applicableStudy completedNCT00002029
What this trial is testing

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

Who this might be right for
HIV Infections
Abbott
Early research (Phase 1)Study completedNCT02059031
What this trial is testing

Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 24
Not applicableUnknownNCT00951886
What this trial is testing

The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally

Who this might be right for
Ataxia Telangiectasia
Sheba Medical Center 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation